Bowel perforation: Difference between revisions

No edit summary
Line 114: Line 114:
# Rhodes, A., Evans, L.E., Alhazzani, W. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 43, 304–377 (2017). https://doi.org/10.1007/s00134-017-4683-6.
# Rhodes, A., Evans, L.E., Alhazzani, W. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 43, 304–377 (2017). https://doi.org/10.1007/s00134-017-4683-6.
# Joseph S. Solomkin, John E. Mazuski, John S. Bradley, Keith A Rodvold, Ellie J.C. Goldstein, Ellen J. Baron, Patrick J. O'Neill, Anthony W. Chow, E. Patchen Dellinger, Soumitra R. Eachempati, Sherwood Gorbach, Mary Hilfiker, Addison K. May, Avery B. Nathens, Robert G. Sawyer, John G. Bartlett, Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 50, Issue 2, 15 January 2010, Pages 133–164, https://doi.org/10.1086/649554.
# Joseph S. Solomkin, John E. Mazuski, John S. Bradley, Keith A Rodvold, Ellie J.C. Goldstein, Ellen J. Baron, Patrick J. O'Neill, Anthony W. Chow, E. Patchen Dellinger, Soumitra R. Eachempati, Sherwood Gorbach, Mary Hilfiker, Addison K. May, Avery B. Nathens, Robert G. Sawyer, John G. Bartlett, Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 50, Issue 2, 15 January 2010, Pages 133–164, https://doi.org/10.1086/649554.
[[Category:Surgery]]
[[Category:GI]]

Revision as of 18:09, 21 May 2020

Background

Bowel perforation describes a full-thickness breach of the intestinal wall, allowing air and/or gastrointestinal contents to enter the surrounding peritoneal cavity, which can be a potentially life-threatening cause of sepsis. Perforation typically presents acutely (i.e., appendicitis, diverticulitis, perforated peptic ulcer, penetrating trauma) and often requires immediate surgical intervention. However, when the perforation is immediately contained (i.e., by the omentum or retroperitoneum) it may occasionally present with a more indolent course. Similarly, immunosuppression or systemic corticosteroid therapy may blunt the inflammatory response resulting in a protracted, indolent presentation.

Clinical Features

  • Primary features:
    • Abdominal pain, abdominal distention / rigidity (see acute abdomen)
      • Occasionally focal if regionally confined (less common)
    • Nausea, vomiting, fever, and anorexia often present
  • Secondary features:
    • Sepsis (fever, leukocytosis, tachycardia, hypotension)
    • Possible sepsis-related end-organ dysfunction (i.e., ARDS, renal failure)

Causes1,2

  • Peptic ulcer disease
  • Malignancy
  • Diverticulitis
  • Appendicitis
  • Abdominal trauma (penetrating > blunt)
  • Bowel obstruction
  • Foreign body ingestion
  • Necrotizing enterocolitis (premature infants)
  • Iatrogenic (i.e., endoscopy)

Differential Diagnosis

Evaluation1,2

  • Physical exam
    • Perforation with peritonitis
      • Abdominal tenderness, distention
      • Involuntary guarding
      • Rebound tenderness
    • Perforation without peritonitis
      • Abdominal tenderness
      • Voluntary guarding
  • Imaging (use only if physical exam is non-specific, exam findings of peritonitis warrant immediate surgical consultation):
    • X-ray
      • 3 views of the abdomen (upright, supine, and left lateral decubitus) and upright CXR
    • CT abdomen/pelvis with IV contrast (and PO contrast if possible)
      • IV contrast improves soft tissue resolution in the abdomen and pelvis and improves diagnostic accuracy and should be considered even in the presence of acute kidney injury.
      • PO contrast improves bowel resolution and the identification of perforation. Presence of PO contrast may help to distinguish intra-abdominal abscesses from adjacent bowel.

Management1,3-4

  • Intravenous fluid resuscitation3
    • Resuscitation guidelines for sepsis (taken from the Surviving Sepsis Campaign 2016 recommendations):
      • For sepsis-induced hypoperfusion, administration of 30 mL/kg of IV isotonic crystalloid within first 3 hrs
        • Additional fluid resuscitation should be guided by frequent reassessment of hemodynamic status
      • Guide resuscitation to normalize lactate in patients with elevated lactate levels as a marker of tissue hypoperfusion
      • Initial target mean arterial pressure (MAP) of 65 mmHg in patients with septic shock requiring vasopressors
  • Microbiology cultures: Routine microbiology cultures should be obtained prior to starting antimicrobial therapy, as long as this does not delay the initiation of antimicrobial therapy.
  • Initiate broad-spectrum antibiotics (start as soon as possible; ideally within the first hour)4
    • Community-acquired:
      • Therapy should target enteric gram-negative aerobic and facultative bacilli, obligate anaerobic bacilli, and enteric gram-positive streptococci
      • Adult regimen (see TABLE 1):
        • Mild to moderate severity community acquired GI perforation:
          • Single agent: Cefoxitin, ertapenem, moxifloxacin, tigecycline, or ticarcillin/clavulanic acid
          • Combination therapy:
            • Cefazolin, cefuroxime, ceftriaxone, cefotaxime, ciprofloxacin, or levofloxacin -AND-
            • Metronidazole
        • High risk/severity community acquired GI perforation:
          • Single agent: Imipenem-cilastatin, meropenem, doripenem, or piperacillin/tazobactam
          • Combination therapy: Cefepime, ceftazidime, ciprofloxacin, or levofloxacin -AND-
          • Metronidazole
      • Pediatric regimen: (for dosage, see TABLE 1)
        • Community acquired GI perforation:
          • Single agent: Ertapenem, meropenem, imipenem-cilastatin, ticarcillin/clavulanate, and piperacillin/tazobactam
          • Combination therapy:
            • Ceftriaxone, cefotaxime, cefepime, or ceftazidime, each in combination with metronidazole
            • Gentamicin or tobramycin, each in combination with metronidazole or clindamycin, and with or without ampicillin
    • Iatrogenic/hospital-associated perforation: Therapy should be driven by local microbiologic results.
      • Drug-resistant bacteria regimen (common in hospital-associated perforation):
        • <20% Resistant Resudomonas aeruginosa, ESBL-producing Enterobacteriaceae, Acinetobacter, or other MDR GNB:
          • Single agent: Carbapenem, piperacillin-tazobactam
          • Ceftazidime or cefepime, each in combination with metronidazole
        • ESBL-producing Enterobacteriaceae: Carbapenem, piperacillin/tazobactam, or aminoglycoside
        • P. aeruginosa >20% resistant to ceftazidime: Carbapenem, piperacillin/tazobactam, or aminoglycoside
        • MRSA: Vancomycin only
    • Fungal infection: Antifungal therapy for patients with severe community-acquired or health care-associated infection is recommended if Candida is grown from intra-abdominal cultures (fluconazole; echinocandins for triazole-resistant species)
  • Designate patient as NPO1
  • Obtain surgical consult1

Disposition1

  • Obtain immediate surgical consult

TABLE 1. Antibiotic Dosage Information4

File:TABLE 1. Antibiotic dosage information.pdf

See Also

External Links

References

  1. Sabiston, David C.,Townsend, Courtney M.,eds. Sabiston Textbook Of Surgery: The Biological Basis Of Modern Surgical Practice. Philadelphia, PA : Elsevier Saunders, 2012.
  2. Tanner, T., Hall, B., & Oran, J. (2018). Pneumoperitoneum. Surgical Clinics of North America., 98(5), 915–932. https://doi.org/10.1016/j.suc.2018.06.004.
  3. Rhodes, A., Evans, L.E., Alhazzani, W. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 43, 304–377 (2017). https://doi.org/10.1007/s00134-017-4683-6.
  4. Joseph S. Solomkin, John E. Mazuski, John S. Bradley, Keith A Rodvold, Ellie J.C. Goldstein, Ellen J. Baron, Patrick J. O'Neill, Anthony W. Chow, E. Patchen Dellinger, Soumitra R. Eachempati, Sherwood Gorbach, Mary Hilfiker, Addison K. May, Avery B. Nathens, Robert G. Sawyer, John G. Bartlett, Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 50, Issue 2, 15 January 2010, Pages 133–164, https://doi.org/10.1086/649554.